These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31286351)

  • 21. The enhanced antitumor-specific immune response with mannose- and CpG-ODN-coated liposomes delivering TRP2 peptide.
    Lai C; Duan S; Ye F; Hou X; Li X; Zhao J; Yu X; Hu Z; Tang Z; Mo F; Yang X; Lu X
    Theranostics; 2018; 8(6):1723-1739. PubMed ID: 29556352
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dendritic cells crosspresent antigens from live B16 cells more efficiently than from apoptotic cells and protect from melanoma in a therapeutic model.
    Matheoud D; Baey C; Vimeux L; Tempez A; Valente M; Louche P; Le Bon A; Hosmalin A; Feuillet V
    PLoS One; 2011 Apr; 6(4):e19104. PubMed ID: 21552572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design and evaluation of theranostic perfluorocarbon particles for simultaneous antigen-loading and ¹⁹F-MRI tracking of dendritic cells.
    Dewitte H; Geers B; Liang S; Himmelreich U; Demeester J; De Smedt SC; Lentacker I
    J Control Release; 2013 Jul; 169(1-2):141-9. PubMed ID: 23567042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy.
    van Broekhoven CL; Parish CR; Demangel C; Britton WJ; Altin JG
    Cancer Res; 2004 Jun; 64(12):4357-65. PubMed ID: 15205352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of antitumor immunity with dendritic cells transduced with adenovirus vector-encoding endogenous tumor-associated antigens.
    Kaplan JM; Yu Q; Piraino ST; Pennington SE; Shankara S; Woodworth LA; Roberts BL
    J Immunol; 1999 Jul; 163(2):699-707. PubMed ID: 10395660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapy of established tumour with a hybrid cellular vaccine generated by using granulocyte-macrophage colony-stimulating factor genetically modified dendritic cells.
    Cao X; Zhang W; Wang J; Zhang M; Huang X; Hamada H; Chen W
    Immunology; 1999 Aug; 97(4):616-25. PubMed ID: 10457215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multispectral MRI with Dual Fluorinated Probes to Track Mononuclear Cell Activity in Mice.
    Chirizzi C; De Battista D; Tirotta I; Metrangolo P; Comi G; Bombelli FB; Chaabane L
    Radiology; 2019 May; 291(2):351-357. PubMed ID: 30888930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy.
    Kim HR; Park JS; Park JH; Yasmin F; Kim CH; Oh SK; Chung IJ; Jun CD
    J Hematol Oncol; 2021 Mar; 14(1):43. PubMed ID: 33731208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo tracking and immunological properties of pulsed porcine monocyte-derived dendritic cells.
    Crisci E; Fraile L; Novellas R; Espada Y; Cabezón R; Martínez J; Cordoba L; Bárcena J; Benitez-Ribas D; Montoya M
    Mol Immunol; 2015 Feb; 63(2):343-54. PubMed ID: 25282042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embryonic stem cell-derived dendritic cells expressing glypican-3, a recently identified oncofetal antigen, induce protective immunity against highly metastatic mouse melanoma, B16-F10.
    Motomura Y; Senju S; Nakatsura T; Matsuyoshi H; Hirata S; Monji M; Komori H; Fukuma D; Baba H; Nishimura Y
    Cancer Res; 2006 Feb; 66(4):2414-22. PubMed ID: 16489048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved efficacy of dendritic cell-based immunotherapy by cutaneous laser illumination.
    Chen X; Zeng Q; Wu MX
    Clin Cancer Res; 2012 Apr; 18(8):2240-9. PubMed ID: 22392913
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A defined serum-free medium useful for monitoring anti-melanoma responses induced by dendritic cell immunotherapy.
    Bouwer AL; Netter P; Kemp RA; McLellan AD
    J Immunol Methods; 2010 Jan; 352(1-2):178-81. PubMed ID: 19903484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of prostaglandin E2-induced dendritic cell migration into the lymph nodes of mice using a 1.5 T clinical MR scanner.
    Joo HJ; Kim HS; Choi YS; Kim H; Kim SJ; Moon WK
    NMR Biomed; 2012 Apr; 25(4):570-9. PubMed ID: 22009917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transfection of immature murine bone marrow-derived dendritic cells with the granulocyte-macrophage colony-stimulating factor gene potently enhances their in vivo antigen-presenting capacity.
    Curiel-Lewandrowski C; Mahnke K; Labeur M; Roters B; Schmidt W; Granstein RD; Luger TA; Schwarz T; Grabbe S
    J Immunol; 1999 Jul; 163(1):174-83. PubMed ID: 10384114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enhanced antitumor effects induced by lymphotactin gene-modified dendritic cells after pulsed with tumor antigen peptide].
    Zhang W; He L; Cao X
    Zhonghua Yi Xue Za Zhi; 1999 Mar; 79(3):170-3. PubMed ID: 11601032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relevance of the tumor antigen in the validation of three vaccination strategies for melanoma.
    Bellone M; Cantarella D; Castiglioni P; Crosti MC; Ronchetti A; Moro M; Garancini MP; Casorati G; Dellabona P
    J Immunol; 2000 Sep; 165(5):2651-6. PubMed ID: 10946294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
    Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
    Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Enrichment of Dendritic Cell Vaccine in Lymph Node with Fluorescent-Magnetic Nanoparticles Enhanced Cancer Immunotherapy.
    Jin H; Qian Y; Dai Y; Qiao S; Huang C; Lu L; Luo Q; Chen J; Zhang Z
    Theranostics; 2016; 6(11):2000-2014. PubMed ID: 27698936
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of tumor immunity and cytotoxic t lymphocyte responses using dendritic cells transduced by adenoviral vectors encoding HBsAg: comparison to protein immunization.
    Qiu SJ; Lu L; Qiao C; Wang L; Wang Z; Xiao X; Qian S; Fung JJ; Ye SL; Bonham CA
    J Cancer Res Clin Oncol; 2005 Jul; 131(7):429-38. PubMed ID: 15818505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.